Dabur India Ltd - Company Profile
Powered by 
All the data and insights you need on Dabur India Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Dabur India Ltd Strategy Report
- Understand Dabur India Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Dabur India Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| CN101203524B | Grant | Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides | C07H13/08; C07H19/073; Y02P20/55 | June 15, 2011 |
| US7781398B2 | Grant | Drug comprising synthetic peptide analogs for the treatment of cancer | A61K38/08; A61P35/00 | August 24, 2010 |
| UA088940C2 | Grant | INTERMEDIATE, PROCESS FOR PREPARING THEREOF AND STEREOSELECTIVE GLYCOSYLATION PROCESS | C07H13/08; C07H19/073; Y02P20/55 | December 10, 2009 |
| BRPI0520050A2 | Application | composto, processo para a preparação de um composto e processo de glicosilação estereoseletiva para a preparação de mais de 99% de anÈmero b enriquecido de hidrocloreto de gencitabina | C07H13/08; C07H19/073; Y02P20/55 | November 17, 2009 |
| NZ560735A | Application | Intermediate and process for preparing the beta-anomer of gemcitabine hydrochloride via a low temperature stereoselective glycosylation reaction | C07H13/08; C07H19/073; Y02P20/55; C07H19/73 | July 31, 2009 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer